Balsm Alofoq Medicalشركة بلسم الأفق الطبية
- Price
- 24.19 SAR
- Fair value
- 9.72 SAR
- Discount to fair value
- −149%
- Mkt cap
- 60.48M
- P/E
- 30.7×
- P/B
- 1.96×
- EV
- 51.14M
- ROE
- 6.4%
- Net margin
- 9.7%
Current price24.19SAR
Fair value (est., median)9.72SAR
UndervaluedFair valueOvervalued
+148.8% above fair valueWould need to fall ~59.8% to reach fair value.
Median ofGraham 16.85Residual Income 8.67Earnings Power 9.72
Health Check
34.6
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Healthy balance sheet.
Risks
- Trades 148.9% above estimated fair value.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 3 years · FY2023–FY2025
| Metric | FY'23 | FY'24 | FY'25 |
|---|---|---|---|
| Revenue | 18.03M | 19.86M | 20.38M |
| Net Income | 4.16M | 4.78M | 1.97M |
| Net Margin | 23.1% | 24.1% | 9.7% |
| Operating Cash Flow | 5.41M | 5.48M | -2.94M |
| OCF Margin | 30.0% | 27.6% | -14.4% |
| Capital Expenditure | 7.15M | 210.7K | 4.15M |
| Free Cash Flow | -1.74M | 5.27M | -7.10M |
| FCF Margin | -9.7% | 26.5% | -34.8% |
| FCF Conversion | -41.8% | 110.3% | -360.7% |
| EPS (Diluted) | 1.66/sh | 1.91/sh | 0.79/sh |
| Dividend / Share | 0.38/sh | 1.20/sh | — |
Dividend return (if you buy today)
This company doesn’t currently pay a dividend, so there’s no income return to project. The fair-value gauge above covers the price side.
Dividend history
Dividend / share & historical yield (SAR).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · SAR
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — |
| 2024 | — | — | — | — | 1.20 | 3.2% |
| 2023 | — | — | — | — | 0.38 | — |
Corporate actions
SStock Split
2×2025-12-22
Valuation breakdown
Fair value = median of the applicable methods (Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Excluded — non-positive free cash flow
N/A
Dividend Discount Model
Excluded — company pays no dividend
N/A
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
16.85
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
8.67
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
9.72
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)9.72
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 10.37%
- CAPM cost of equity
- 10.50%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Balsm Alofoq Medical regularly?
Starting year
- Invested
- 1K/yr · 3K total(2024 → today · 3 yrs)
- your value today is
- 2.2K SAR
- Total return
- -26.7%(+1.2% Dividends · -28.0% Capital gain)
- Annualised (IRR)
- -21.1%
Invested3KSAR
Dividends37SAR
Capital gain-839SAR
InvestedCapital gainDividendstap a bar for figures
Major shareholders
As of 2026-06-16Disclosed holders at or above the 5% reporting threshold.
خميس عبدالله دحيلان الحربي
60.00%
غدير خميس عبدالله الحربي
6.00%
وقف الدكتور راشد بن حسين بن مهدي قعوان
5.36%
رغد خميس عبدالله الظعيني الحربي
5.00%
Total disclosed76.36%
The Saudi Exchange publishes only holders at or above 5%; smaller stakes are not disclosed.
Community Notes0
No notes yet. Be the first to share a thesis.